Marken President Ariette Van Strien addresses whether the momentum toward decentralized trials will continue after the pandemic

“As an industry, each and every one of us plays a part in ensuring that decentralized trials continue to take hold and find increasing traction and success,” she says. “The question of whether or not the momentum can be maintained post-COVID-19 simply isn’t a question or an option. It’s an imperative.”

You can rely on us when it comes to decentralizing clinical trials because we are a wholly owned subsidiary of UPS and the essential clinical part of UPS Healthcare. With Marken, BOMI Group, and Polar Speed included, the UPS Healthcare network staffs 199 locations with 10,000+ employees worldwide.